Celex Oncology Innovations Ltd

๐Ÿ“ London, United Kingdom๐Ÿ‘ฅ 11 employees๐Ÿ’ฐ Last funded Jan 2024
Celex is a leading biotechnology company focused on the research and development of cutting-edge cancer treatments. Our team of experienced scientists and physicians are dedicated to improving the lives of those affected by cancer through the discovery and development of innovative therapeutics. Utilising cutting-edge technology, developed by Professor Djamgoz over the course of 20 years of research, and a deep understanding of the underlying biology of cancer, we strive to bring new and effective treatment options to patients in need. Celex Oncology is committed to advancing the fight against cancer and improving the lives of those affected by this disease. Get in touch with the team today to learn more about our revolutionary therapeutics. Celex Oncology are currently raising capital to advance our research and make invasive tumours benign. Contact us to learn more!
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
โ€”
Founded
Investor geography1 country
Guernsey
1
Frequently asked questions
Who invested in Celex Oncology Innovations Ltd?
Celex Oncology Innovations Ltd has 1 investors on record on gritt.io.
When did Celex Oncology Innovations Ltd last raise funding?
The most recent investment in Celex Oncology Innovations Ltd recorded on gritt.io was in January 2024.
What industry is Celex Oncology Innovations Ltd in?
Celex Oncology Innovations Ltd operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Celex Oncology Innovations Ltd based?
Celex Oncology Innovations Ltd is headquartered in London, United Kingdom.